Folgen
Aljoša Bolje
Aljoša Bolje
Assistant-researcher, Faculty of Chemistry and Chemical Technology, University of Ljubljana
Bestätigte E-Mail-Adresse bei fkkt.uni-lj.si - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Catalytic oxygenation of sp 3 “C–H” bonds with Ir (III) complexes of chelating triazoles and mesoionic carbenes
S Hohloch, S Kaiser, FL Duecker, A Bolje, R Maity, J Košmrlj, B Sarkar
Dalton Transactions 44 (2), 686-693, 2015
792015
A selective approach to pyridine appended 1, 2, 3-triazolium salts
A Bolje, J Kosmrlj
Organic letters 15 (19), 5084-5087, 2013
762013
Exploring the scope of pyridyl-and picolyl-functionalized 1, 2, 3-triazol-5-ylidenes in bidentate coordination to ruthenium (II) cymene chloride complexes
A Bolje, S Hohloch, D Urankar, A Pevec, M Gazvoda, B Sarkar, ...
Organometallics 33 (10), 2588-2598, 2014
742014
A mesoionic bis (Py-tz NHC) palladium (II) complex catalyses “green” Sonogashira reaction through an unprecedented mechanism
M Gazvoda, M Virant, A Pevec, D Urankar, A Bolje, M Kočevar, J Košmrlj
Chemical Communications 52 (8), 1571-1574, 2016
702016
RuII, OsII, and IrIII Complexes with Chelating Pyridyl–Mesoionic Carbene Ligands: Structural Characterization and Applications in Transfer Hydrogenation Catalysis
A Bolje, S Hohloch, M van der Meer, J Košmrlj, B Sarkar
Chemistry–A European Journal 21 (18), 6756-6764, 2015
692015
Ru II, Ir III and Os II mesoionic carbene complexes: efficient catalysts for transfer hydrogenation of selected functionalities
A Bolje, S Hohloch, J Košmrlj, B Sarkar
Dalton Transactions 45 (40), 15983-15993, 2016
542016
Synthesis and NMR Analysis of 1, 4‐Disubstituted 1, 2, 3‐Triazoles Tethered to Pyridine, Pyrimidine, and Pyrazine Rings
A Bolje, D Urankar, J Košmrlj
European Journal of Organic Chemistry 2014 (36), 8167-8181, 2014
442014
Half-sandwich Ir (III) and Os (II) complexes of pyridyl-mesoionic carbenes as potential anticancer agents
J Kralj, A Bolje, DS Polančec, I Steiner, T Gržan, A Tupek, N Stojanović, ...
Organometallics 38 (21), 4082-4092, 2019
212019
Discovery of ‘click’1, 2, 3-triazolium salts as potential anticancer drugs
I Steiner, N Stojanovic, A Bolje, A Brozovic, D Polancec, ...
Radiology and Oncology 50 (3), 280, 2016
212016
Analytical techniques for structural characterization of proteins in solid pharmaceutical forms: an overview
A Bolje, S Gobec
Pharmaceutics 13 (4), 534, 2021
152021
Structural characterization and stability of proteins in solid forms
A Bolje, S Gobec
FEBS OPEN BIO 11, 173-173, 2021
2021
Project report (for Faculty of Pharmacy): Structural characterization of proteins in solid pharmaceutical forms
A Bolje
Project report published on the Faculty of Pharmacy's web page, 2021
2021
Analytical Techniques for Structural Characterization of Proteins in Solid Pharmaceutical Forms: An Overview. Pharmaceutics 2021, 13, 534
A Bolje, S Gobec
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
2021
Ir (III)-arene complexes as active catalysts for the oxidation of sp3 CH bonds
S Hohloch, S Kaiser, FL Duecker, A Bolje, R Maity, J Kosmrlj, B Sarkar
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016
2016
Organometallic iridium complexes as potential anticancer drugs
T Gržan, J Kralj, A Bolje, A Tupek, I Steiner, N Stojanović, S Hochloch, ...
Cellular signalling and cancer therapy-EMBO Conference, 2016
2016
Inside Back Cover: RuII, OsII, and IrIII Complexes with Chelating Pyridyl–Mesoionic Carbene Ligands: Structural Characterization and Applications in Transfer …
A Bolje, S Hohloch, M van der Meer, J Košmrlj, B Sarkar
Chemistry–A European Journal 21 (18), 6963-6963, 2015
2015
Sinteza in Koordinativne Lastnosti Novih Triazolskih Ligandov: Doktorska Disertacija
A Bolje
A. Bolje, 2015
2015
‘Click’derived 1, 2, 3-triazolium salts as potential anticancer drugs
I Steiner, N Stojanović, A Bolje, A Ambriović-Ristov, A Brozovic, ...
" From Bench to Clinic" Third Meeting of the Croatian Association for cancer …, 2014
2014
Sinteza triazolov iz (heteroaril) metil azidov in fenilacetilenov
A Bolje
A. Bolje, 2011
2011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–19